Late Breaking Clinical Trial Abstracts AM22
The Late Breaking Clinical Trial Abstract submission site is now closed. Notifications will be distributed mid-March 2022.
Abstract submissions may be submitted for Plenary and Simultaneous Breakout Sessions within each of the categories below.
Waiver of mandatory manuscript submission for publication in JTCVS may be requested at the time of submission. The requirement for manuscript submission to the JTCVS does not apply to Abstracts for the C. Walton Lillehei Resident Forum, posters, or case videos.
Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with acquired cardiovascular conditions.Submission Guidelines
Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with congenital disorders of the heart, lungs, and great vessels.Submission Guidelines
Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with benign and malignant conditions of the lungs, airways, mediastinum, diaphragm, and chest wall.Submission Guidelines
Presentations that address perioperative evaluation and management including, but not limited to, all pre- and post-operative care and benchmarks of enhancing recovery after cardiac and thoracic surgery (ERAS); patient safety challenges; ECPR and ECMO circulatory management; evidence-based trials of critical care pathways; and ethical dilemmas such as failure to rescue and urgent perioperative revascularization.Submission Guidelines
Presentations on subjects, which the submitter is uncertain about the proper category such as surgical education and training, quality assurance, workforce issues or other broad programs that do not fit neatly into one of the other categories.Submission Guidelines